Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

Gut

Volumn 50, Issue 1, 2002, Pages 123-128

  Llovet, J M ^a   Mas, X ^b   Aponte, J J ^b   Fuster, J ^a   Navasa, M ^a   Christensen, E ^c   Rodes J ^a   Bruix, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; HOSPITAL ADMISSION; HUMAN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; ORGAN DONOR; PATIENT CODING; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ETHANOL; HUMANS; LIFE EXPECTANCY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MARKOV CHAINS; MODELS, ECONOMIC; PATIENT DROPOUTS; SENSITIVITY AND SPECIFICITY; WAITING LISTS;

EID: 0036135389     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.1.123     Document Type: Article

References (39)

1. Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy
2. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure
3. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcer in Japan
4. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
5. Surgical treatment for hepatocellular carcinoma
6. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
7. Liver transplantation for treatment of small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
8. Liver transplantation for hepatocellular carcinoma
9. Limits to liver transplantation in UK
10. Liver transplantation for hepatocellular carcinomas > 5 cm diameter: Results of a multimodality protocol
11. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
12. Liver transplantation for malignant disease
13. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit?
14. Liver transplantation for hepatocellular carcinoma: Results with preoperative chemoembolization
15. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma
16. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma
17. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine
18. Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine
19. Tumor sizes determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma
20. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
21. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection
22. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: Analysis of 71 patients
23. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma
24. Increased risk of tumor seeding after radiofrequency thermal ablation for single hepatocellular carcinoma
25. Natural history of untreated non-surgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
26. Gains in life expectancy from medical interventions-standardizing data on outcomes
27. Health-related quality of life after transplantation: A meta-analysis
28. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
29. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer
30. Five-hundred life-saving interventions and their cost-effectiveness
31. Cost-efectiveness of accepted measures for intervention in coronary heart disease
32. Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis
33. Live donor liver transplantation for early hepatocellular carcinoma: A cost-effectiveness perspective
34. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome oriented decision analysis
35. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
36. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: A pilot study in 20 patients
37. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation